FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: Activation is not required for repair of Cr(VI)-induced DSBs

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 610, Issue 1-2, 2006, Pages 21-30

  Vilcheck, Susan K ^a   Ceryak, Susan ^a   O'Brien, Travis J ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carcinogen; Chromium; DNA interstrand crosslinks; Double strand breaks; Fanconi anemia; Genotoxin; H2AX; Homologous recombination; Human lung cells

Indexed keywords

CHROMIUM; DOUBLE STRANDED DNA; FANCONI ANEMIA GROUP D2 PROTEIN; GAMMA HISTONE H2AX; HISTONE H2AX; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA STRAND BREAKAGE; FANCONI ANEMIA; FIBROBLAST; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SCHOOL CHILD; UBIQUITINATION;

BLOTTING, WESTERN; CELLS, CULTURED; CHILD; CHROMIUM; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FLOW CYTOMETRY; HISTONES; HUMANS; MALE; S PHASE; UBIQUITIN;

EID: 33749263169     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.06.009     Document Type: Article

References (79)

1. D'Andrea A.D., and Grompe M. The Fanconi anaemia/BRCA pathway. Nat. Rev., Cancer 3 (2003) 23-34 [Review, 120 refs]
2. Fujiwara Y. Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells. Biochim. Biophys. Acta 699 (1982) 217-225
3. Zhen W., Evans M.K., Haggerty C.M., and Bohr V.A. Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines. Carcinogenesis 14 (1993) 919-924
4. Rosselli F., Briot D., and Pichierri P. The Fanconi anemia pathway and the DNA interstrand cross-links repair. Biochimie 85 (2003) 1175-1184
5. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 97 (2003) 425-440
6. Rosenberg P.S., Greene M.H., and Alter B.P. Cancer incidence in persons with Fanconi anemia. Blood 101 (2003) 822-826
7. Van Waes C. Head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch. Otolaryngol. Head Neck Surg. 131 (2005) 640-641
8. Rey J.P., Scott R., and Muller H. Induction and removal of interstrand crosslinks in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia. Mutat. Res. 289 (1993) 171-180
9. Joenje H., Oostra A.B., Wijker M., di Summa F.M., van Berkel C.G., Rooimans M.A., Ebell W., van Weel M., Pronk J.C., Buchwald M., and Arwert F. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61 (1997) 940-944
10. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F., Oostra A.B., Mathew C.G., Hoatlin M.E., Waisfisz Q., Arwert F., de Winter J.P., and Joenje H. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103 (2004) 2498-2503
11. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
12. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358 (1992) 434
13. Foe J.R., Rooimans M.A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D.F., Savoia A., Cheng N.C., van Berkel C.G., Strunk M.H., Gille J.J., Pals G., Kruyt F.A., Pronk J.C., Arwert F., Buchwald M., and Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14 (1996) 488
14. de Winter J.P., Leveille F., van Berkel C.G., Rooimans M.A., van Der W.L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K., Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., and Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67 (2000) 1306-1308
15. de Winter J.P., Rooimans M.A., van Der W.L., van Berkel C.G., Alon N., Bosnoyan-Collins L., de Groot J., Zhi Y., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G., Scheper R.J., Hoatlin M.E., Buchwald M., and Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24 (2000) 15-16
16. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., and Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20 (1998) 281-283
17. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A.D., Moses R., and Grompe M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7 (2001) 241-248
18. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
19. Garcia-Higuera I., Kuang Y., Naf D., Wasik J., and D'Andrea A.D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19 (1999) 4866-4873
20. de Winter J.P., van Der W.L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.J., Kruyt F.A., Hoatlin M.E., and Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9 (2000) 2665-2674
21. Medhurst A.L., Huber P.A., Waisfisz Q., de Winter J.P., and Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10 (2001) 423-429
22. Grompe M., and D'Andrea A. Fanconi anemia and DNA repair. Hum. Mol. Genet. 10 (2001) 2253-2259
23. Waisfisz Q., de Winter J.P., Kruyt F.A., de Groot J., van Der W.L., Dijkmans L.M., Zhi Y., Arwert F., Scheper R.J., Youssoufian H., Hoatlin M.E., and Joenje H. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10320-10325
24. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., and D'Andrea A.D. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
25. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
26. IARC, Chromium, Nickel and Welding, vol. 49, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1990, pp. 1-648 [Erratum: in IARC Monogr Eval Carcinogen Risks Hum 51 (1991) 483].
27. Plunkett E.R. Handbook of Industrial Toxicology (1976), Chemical Publishing, New York, NY
28. Cassarett and Doull's Toxicology (1991), Maxwell-MacMillan-Pergamon, New York, NY
29. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., and Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54 (1994) 2342-2346
30. Gochfeld M. Setting the research agenda for chromium risk assessment. Environ. Health Perspect. 92 (1991) 3-5
31. Fishbein L. Sources, transport and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ. Health Perspect. 40 (1981) 43-64
32. International Agency for Research on Cancer, Chromium, Nickel and Welding, vol. 49. Monographs on the evaluation of the carcinogenic risk to humans. International Agency for Research on Cancer, Lyon, 1990, pp. 1-648.
33. Leonard A., and Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76 (1980) 227-239 [Review, 63 refs]
34. Cohen M.D., Kargacin B., Klein C.B., and Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 23 (1993) 255-281 [Review, 340 refs]
35. De Flora S., Bagnasco M., Serra D., and Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 238 (1990) 99-172 [Review, 257 refs]
36. Sugden K.D., and Martin B.D. Guanine and 7,8-dihydro-8-oxo-guanine-specific oxidation in DNA by chromium(V). Environ. Health Perspect. 110 Suppl. 5 (2002) 725-728
37. Sugden K.D., Campo C.K., and Martin B.D. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity. Chem. Res. Toxicol. 14 (2001) 1315-1322
38. Miller III C.A., and Costa M. Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate. Mol. Carcinogen. 1 (1988) 125-133
39. Standeven A.M., and Wetterhahn K.E. Chromium (VI) toxicity: uptake, reduction, and DNA damage. J. Am. Cell. Toxicol. 8 (1989) 1275-1283
40. Singh J., Mclean J.A., Pritchard D.E., Montaser A., and Patierno S.R. Sensitive quantitation of chromium-DNA adducts by inductively coupled plasma mass spectrometry with a direct injection high-efficiency nebulizer. Toxicol. Sci. 46 (1998) 260-265
41. Xu J., Manning F.C., and Patierno S.R. Preferential formation and repair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis 15 (1994) 1443-1450
42. Xu J., Bubley G.J., Detrick B., Blankenship L.J., and Patierno S.R. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17 (1996) 1511-1517
43. Singh J., Bridgewater L.C., and Patierno S.R. Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA. Toxicol. Sci. 45 (1998) 72-76
44. Bridgewater L.C., Manning F.C., and Patierno S.R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis 15 (1994) 2421-2427
45. Singh J., Carlisle D.L., Pritchard D.E., and Patierno S.R. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol. Rep. 5 (1998) 1307-1318 [Review, 84 refs]
46. Bridgewater L.C., Manning F.C., Woo E.S., and Patierno S.R. DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinogen. 9 (1994) 122-133
47. Manning F.C., Xu J., and Patierno S.R. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinogen. 6 (1992) 270-279
48. Patierno S.R., Banh D., and Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48 (1988) 5280-5288
49. Patierno S.R., and Landolph J.R. Soluble vs insoluble hexavalent chromate. Relationship of mutation to in vitro transformation and particle uptake. Biol. Trace Element Res. 21 (1989) 469-474
50. Zhitkovich A., Song Y., Quievryn G., and Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40 (2001) 549-560
51. Tully D.B., Collins B.J., Overstreet J.D., Smith C.S., Dinse G.E., Mumtaz M.M., and Chapin R.E. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol. Appl. Pharmacol. 168 (2000) 79-90
52. Wetterhahn K.E., and Hamilton J.W. Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression. Sci. Total Environ. 86 (1989) 113-129
53. Hamilton J.W., Kaltreider R.C., Bajenova O.V., Ihnat M.A., McCaffrey J., Turpie B.W., Rowell E.E., Oh J., Nemeth M.J., Pesce C.A., and Lariviere J.P. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ. Health Perspect. 106 Suppl. 4 (1998) 1005-1015
54. Ha L., Ceryak S., and Patierno S.R. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of {gamma}-H2AX. Carcinogenesis 25 (2004) 2265-2274
55. Vilcheck S.K., O'Brien T.J., Pritchard D.E., Ha L., Ceryak S., Fornsaglio J.L., and Patierno S.R. Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity. Environ. Health Perspect. 110 Suppl. 5 (2002) 773-777
56. Ha L., Ceryak S., and Patierno S.R. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein: requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278 (2003) 17885-17894
57. Rothfuss A., and Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 24 (2004) 123-134
58. Futaki M., Yamashita T., Yagasaki H., Toda T., Yabe M., Kato S., Asano S., and Nakahata T. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 95 (2000) 1493-1498
59. Gillio A.P., Verlander P.C., Batish S.D., Giampietro P.F., and Auerbach A.D. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 90 (1997) 105-110
60. Qiao F., Moss A., and Kupfer G.M. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J. Biol. Chem. 276 (2001) 23391-23396
61. Wang X., and D'Andrea A.D. The interplay of Fanconi anemia proteins in the DNA damage response. DNA Rep. (Amst.) 3 (2004) 1063-1069
62. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell Biol. 24 (2004) 5850-5862
63. Matsushita N., Kitao H., Ishiai M., Nagashima N., Hirano S., Okawa K., Ohta T., Yu D.S., McHugh P.J., Hickson I.D., Venkitaraman A.R., Kurumizaka H., and Takata M. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19 (2005) 841-847
64. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
65. Thatcher T.H., and Gorovsky M.A. Phylogenetic analysis of the core histones H2A, H2B, H3, and H4. Nucleic Acids Res. 22 (1994) 174-179
66. West M.H., and Bonner W.M. Histone 2A, a heteromorphous family of eight protein species. Biochemistry 19 (1980) 3238-3245
67. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
68. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., and Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5 (2003) 675-679
69. Furuta T., Takemura H., Liao Z.Y., Aune G.J., Redon C., Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T., Nussenzweig A., Aladjem M.I., Bonner W.M., and Pommier Y. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278 (2003) 20303-20312
70. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., and Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10 (2000) 886-895
71. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
72. Helleday T., Nilsson R., and Jenssen D. Arsenic[III] and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells. Environ. Mol. Mutagen. 35 (2000) 114-122
73. Sung P., Trujillo K.M., and Van Komen S. Recombination factors of Saccharomyces cerevisiae. Mutat. Res. 451 (2000) 257-275
74. O'Brien T.J., Fornsaglio J.L., Ceryak S., and Patierno S.R. Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Rep. 1 (2002) 617-627
75. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
76. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. U.S.A 102 (2005) 1110-1115
77. Moynahan M.E., Pierce A.J., and Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7 (2001) 263-272
78. Yamamoto K., Hirano S., Ishiai M., Morishima K., Kitao H., Namikoshi K., Kimura M., Matsushita N., Arakawa H., Buerstedde J.M., Komatsu K., Thompson L.H., and Takata M. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell Biol. 25 (2005) 34-43
79. Park W.H., Margossian S., Horwitz A.A., Simons A.M., D'Andrea A.D., and Parvin J.D. Direct DNA binding activity of the Fanconi anemia D2 protein. J. Biol. Chem. 280 (2005) 23593-23598